Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells

被引:102
作者
He, Lingfeng [1 ]
Zhu, Hong [1 ]
Zhou, Shiying [1 ]
Wu, Ting [1 ]
Wu, Huan [1 ]
Yang, Huan [1 ]
Mao, Huiwen [1 ]
SekharKathera, Chandra [1 ]
Janardhan, Avilala [1 ]
Edick, Ashlin M. [2 ]
Zhang, Anna [3 ]
Hu, Zhigang [1 ]
Pan, Feiyan [1 ]
Guo, Zhigang [1 ]
机构
[1] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 WenYuan Rd, Nanjing 210023, Jiangsu, Peoples R China
[2] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada
[3] Univ Guelph, Dept Psychol, Guelph, ON, Canada
基金
高等学校博士学科点专项科研基金;
关键词
DNA-DAMAGE RESPONSE; HISTONE DEACETYLASES; CHECKPOINT KINASES; P53; CHK1; 5-FLUOROURACIL; CARCINOMA; APOPTOSIS; ATR; MECHANISMS;
D O I
10.1038/s12276-018-0128-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. 5-Fluorouracil (5-FU) is widely used in the treatment of cancers, but its antineoplastic activity is limited in drug-resistant cancer cells. To investigate the detailed mechanism of 5-FU resistance, we developed a model of 5-FU-resistant cells from HCT-8 cells, a well-established colorectal cancer cell line. We found that the drug-resistant cells demonstrated high expression of TCF4 and beta-catenin, indicating an upregulated Wnt pathway. A microarray analysis revealed that the suppression of the checkpoint kinase 1 (CHK1) pathway explained the resistance to 5-FU, especially in p53 wild-type cancer cells such as HCT-8. Our data also demonstrated that the CHK1 pathway is suppressed by the Wnt pathway in 5-FU-resistant cells. In summary, we have discovered a novel mechanism for 5-FU resistance mediated by histone deacetylation, which also revealed the crosstalk between the Wnt pathway and CHK1 pathway.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 39 条
[1]   Flap Endonuclease 1 [J].
Balakrishnan, Lata ;
Bambara, Robert A. .
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82, 2013, 82 :119-138
[2]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[3]   WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited [J].
Boulter, Luke ;
Guest, Rachel V. ;
Kendall, Timothy J. ;
Wilson, David H. ;
Wojtacha, Davina ;
Robson, Andrew J. ;
Ridgway, Rachel A. ;
Samuel, Kay ;
Van Rooijen, Nico ;
Barry, Simon T. ;
Wigmore, Stephen J. ;
Sansom, Owen J. ;
Forbes, Stuart J. .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (03) :1269-1285
[4]   Base-excision repair of oxidative DNA damage [J].
David, Sheila S. ;
O'Shea, Valerie L. ;
Kundu, Sucharita .
NATURE, 2007, 447 (7147) :941-950
[5]  
Didelot C, 2003, INT J ONCOL, V23, P81
[6]   Tumour supressor secreted frizzled related protein 1 regulates p53-mediated apoptosis [J].
Gauger, Kelly J. ;
Schneider, Sallie S. .
CELL BIOLOGY INTERNATIONAL, 2014, 38 (01) :124-130
[7]  
Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458
[8]   Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System [J].
Hat, Beata ;
Kochanczyk, Marek ;
Bogdal, Marta N. ;
Lipniacki, Tomasz .
PLOS COMPUTATIONAL BIOLOGY, 2016, 12 (02)
[9]   Genome maintenance mechanisms for preventing cancer [J].
Hoeijmakers, JHJ .
NATURE, 2001, 411 (6835) :366-374
[10]   TP53 mutation in colorectal cancer [J].
Iacopetta, B .
HUMAN MUTATION, 2003, 21 (03) :271-276